Cargando…

Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity

Plasmodium falciparum-infected erythrocytes (IE) sequester in the placenta via surface protein VAR2CSA, which binds chondroitin sulfate A (CSA) expressed on the syncytiotrophoblast surface, causing placental malaria (PM) and severe adverse outcomes in mothers and their offspring. VAR2CSA belongs to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Renn, Jonathan P., Doritchamou, Justin Y. A., Tentokam, Bergeline C. Nguemwo, Morrison, Robert D., Cowles, Matthew V., Burkhardt, Martin, Ma, Rui, Mahamar, Almahamoudou, Attaher, Oumar, Diarra, Bacary S., Traore, Moussa, Dicko, Alassane, Tolia, Niraj H., Fried, Michal, Duffy, Patrick E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8604988/ https://www.ncbi.nlm.nih.gov/pubmed/34799664 http://dx.doi.org/10.1038/s42003-021-02787-7

Ejemplares similares

Author Correction: Allelic variants of full-length VAR2CSA, the placental malaria vaccine candidate, differ in antigenicity and receptor binding affinity
por: Renn, Jonathan P., et al.
Publicado: (2022)

A single full-length VAR2CSA ectodomain variant purifies broadly neutralizing antibodies against placental malaria isolates
por: Doritchamou, Justin YA, et al.
Publicado: (2022)

Antibody levels to recombinant VAR2CSA domains vary with Plasmodium falciparum parasitaemia, gestational age, and gravidity, but do not predict pregnancy outcomes
por: Fried, Michal, et al.
Publicado: (2018)

Age-dependent increase in antibodies that inhibit Plasmodium falciparum adhesion to a subset of endothelial receptors
por: Attaher, Oumar, et al.
Publicado: (2019)

Effect of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2017)

Pregnancy outcomes in a malaria-exposed Malian cohort of women of child-bearing age
por: Gaoussou, Santara, et al.
Publicado: (2022)

Antibody Levels to Plasmodium falciparum Erythrocyte Membrane Protein 1-DBLγ11 and DBLδ-1 Predict Reduction in Parasite Density
por: Araj, Brittany N., et al.
Publicado: (2021)

Host factors that modify Plasmodium falciparum adhesion to endothelial receptors
por: Mahamar, Almahamoudou, et al.
Publicado: (2017)

Structural basis for placental malaria mediated by Plasmodium falciparum VAR2CSA
por: Ma, Rui, et al.
Publicado: (2021)

Adverse pregnancy outcomes among women presenting at antenatal clinics in Ouélessébougou, Mali
por: Andemel, Naissem, et al.
Publicado: (2020)

Placental malaria vaccine candidate antigen VAR2CSA displays atypical domain architecture in some Plasmodium falciparum strains
por: Doritchamou, Justin Y. A., et al.
Publicado: (2019)

Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2022)

A conformational epitope in placental malaria vaccine antigen VAR2CSA: What does it teach us?
por: Doritchamou, Justin Y. A., et al.
Publicado: (2023)

Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali
por: Mahamar, Almahamoudou, et al.
Publicado: (2021)

Optimal mode for delivery of seasonal malaria chemoprevention in Ouelessebougou, Mali: A cluster randomized trial
por: Barry, Amadou, et al.
Publicado: (2018)

Recent malaria does not substantially impact COVID-19 antibody response or rates of symptomatic illness in communities with high malaria and COVID-19 transmission in Mali, West Africa
por: Woodford, John, et al.
Publicado: (2022)

Designing a VAR2CSA-based vaccine to prevent placental malaria()
por: Fried, Michal, et al.
Publicado: (2015)

IFN-λ4 is associated with increased risk and earlier occurrence of several common infections in African children
por: Prokunina-Olsson, Ludmila, et al.
Publicado: (2021)

Antibody gene features associated with binding and functional activity in vaccine-derived human mAbs targeting malaria parasites
por: Coelho, Camila H., et al.
Publicado: (2023)

Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial
por: Stone, Will, et al.
Publicado: (2022)

Naturally Acquired Antibody Response to Malaria Transmission Blocking Vaccine Candidate Pvs230 Domain 1
por: Tentokam, Bergeline C. Nguemwo, et al.
Publicado: (2019)

Identification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA
por: Doritchamou, Justin, et al.
Publicado: (2015)

Impact of seasonal malaria chemoprevention on hospital admissions and mortality in children under 5 years of age in Ouelessebougou, Mali
por: Issiaka, Djibrilla, et al.
Publicado: (2020)

Var2CSA Minimal CSA Binding Region Is Located within the N-Terminal Region
por: Srivastava, Anand, et al.
Publicado: (2011)

Aotus nancymaae model predicts human immune response to the placental malaria vaccine candidate VAR2CSA
por: Doritchamou, Justin, et al.
Publicado: (2023)

Persistence of mRNA indicative of Plasmodium falciparum ring-stage parasites 42 days after artemisinin and non-artemisinin combination therapy in naturally infected Malians
por: Mahamar, Almahamoudou, et al.
Publicado: (2021)

Rapidly increasing SARS-CoV-2 seroprevalence and limited clinical disease in three Malian communities: a prospective cohort study
por: Sagara, Issaka, et al.
Publicado: (2021)

Phosphorylation of the VAR2CSA extracellular region is associated with enhanced adhesive properties to the placental receptor CSA
por: Dorin-Semblat, Dominique, et al.
Publicado: (2019)

Evidence for the Involvement of VAR2CSA in Pregnancy-associated Malaria
por: Salanti, Ali, et al.
Publicado: (2004)

Structure function analysis of P. falciparum VAR2CSA
por: Dahlbäck, Madeleine, et al.
Publicado: (2010)

Rapidly Increasing Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence and Limited Clinical Disease in 3 Malian Communities: A Prospective Cohort Study
por: Sagara, Issaka, et al.
Publicado: (2021)

Transmission-blocking Effects of Primaquine and Methylene Blue Suggest Plasmodium falciparum Gametocyte Sterilization Rather Than Effects on Sex Ratio
por: Bradley, John, et al.
Publicado: (2019)

Safety, reactogenicity and immunogenicity of a booster dose of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Malian children
por: Dicko, Alassane, et al.
Publicado: (2013)

VAR2CSA Signatures of High Plasmodium falciparum Parasitemia in the Placenta
por: Rovira-Vallbona, Eduard, et al.
Publicado: (2013)

A Plasma Survey Using 38 PfEMP1 Domains Reveals Frequent Recognition of the Plasmodium falciparum Antigen VAR2CSA among Young Tanzanian Children
por: Oleinikov, Andrew V., et al.
Publicado: (2012)

Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial
por: Chen, Ingrid, et al.
Publicado: (2018)

Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali
por: Diawara, Fatou, et al.
Publicado: (2017)

Structural Insight into Epitopes in the Pregnancy-Associated Malaria Protein VAR2CSA
por: Andersen, Pernille, et al.
Publicado: (2008)

Default Pathway of var2csa Switching and Translational Repression in Plasmodium falciparum
por: Mok, Bobo W., et al.
Publicado: (2008)

Utilizing Nanobody Technology to Target Non-Immunodominant Domains of VAR2CSA
por: Ditlev, Sisse B., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_39qrglblcuok75j9irkl118gko